Inflammatory Cytokines Stimulate the Adhesion of Colon Carcinoma Cells to Mesothelial Monolayers

L. Hofland; M. van Rossen; P. van Koetsveld; J. Jeekel; C. van Eijck
October 2007
Digestive Diseases & Sciences;Oct2007, Vol. 52 Issue 10, p2775
Academic Journal
Abstract  Surgical handling of the peritoneum causes an inflammatory reaction, during which a potentially lethal cocktail of active mediators is produced, including cytokines and growth factors. The aim of this study was to investigate the effects of inflammatory cytokines on the interaction between tumor and mesothelial cells. Tumor cell adhesion to a mesothelial monolayer was assessed after preincubation of the mesothelium with interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α. Preincubation of the mesothelial monolayer with IL-1β or TNF-α resulted in enhanced tumor cell adhesion of Caco2 and HT29 colon carcinoma cells. The amount of stimulation for the Caco2 cells was between 20% and 40% and for HT29 cells between 30% and 70%. Blocking experiments with anti–IL-1β and anti–TNF-α resulted in significant inhibition of the cytokine-stimulated tumor cell adhesion. The presented results prove that IL-1β and TNF-α are significant stimulating factors in tumor cell adhesion in vitro and may therefore account for tumor recurrence to the peritoneum in vivo.


Related Articles

  • Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL. Kock, Norman; Kasmieh, Randa; Weissleder, Ralph; Shah, Khalid // Neoplasia;May2007, Vol. 9 Issue 5, p435 

    Tumor necrosis factor--related apoptosis-inducing ligand (TRAIL) can selectively kill tumor cells and, in combination with other agents, could enhance tumor therapy. We explored the combined therapeutic effects of a secretable form of (S) TRAIL-induced apoptosis and the downregulation of Bcl-2...

  • Enhanced Tumor Necrosis Factor-α Expression in Small Sized Abdominal Aortic Aneurysms World J. Surg. Vol. 27, No. 4 April 2003. Hamano, Kimikazu; Li, Tao-Sheng; Takahashi, Mutsuo; Kobayashi, Toshiro; Shirasawa, Bungo; Ito, Hiroshi; Zempo, Nobuya // World Journal of Surgery;Apr2003, Vol. 27 Issue 4, p476 

    Circulating levels of tumor necrosis factor α (TNF-α) are elevated in the patients with abdominal aortic aneurysm (AAA). We investigated TNF-α expression and cellular infiltration in the walls of AAAs of different sizes. Twenty-seven surgical specimens of AAAs were categorized according...

  • TAK1 Is Required for Survival of Mouse Fibroblasts Treated with TRAIL, and Does So by NF-κB Dependent Induction of cFLIPL. Lluis, Josep Maria; Nachbur, Ulrich; Cook, Wendy Diane; Gentle, Ian Edward; Moujalled, Donia; Moulin, Maryline; Wendy Wei-Lynn Wong; Khan, Nufail; Chau, Diep; Callus, Bernard Andrew; Vince, James Edward; Silke, John; Vaux, David Lawrence // PLoS ONE;2010, Vol. 5 Issue 1, p1 

    Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is known as a ''death ligand''-a member of the TNF superfamily that binds to receptors bearing death domains. As well as causing apoptosis of certain types of tumor cells, TRAIL can activate both NF-κB and JNK signalling...

  • Transforming growth factor-β1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts. Nan-Shan Chang // BMC Cell Biology;2002, Vol. 3, p8 

    Background: Functional antagonism between transforming growth factor beta (TGF-β) and hyaluronidase has been demonstrated. For example, testicular hyaluronidase PH-20 counteracts TGF-β1-mediated growth inhibition of epithelial cells. PH-20 sensitizes various cancer cells to tumor necrosis...

  • Antitumor activity of Ad-IU2, a prostate-specific replication-competent adenovirus encoding the apoptosis inducer, TRAIL. Jiménez, J. A.; Li, X.; Zhang, Y.-P.; Bae, K. H.; Mohammadi, Y.; Pandya, P.; Kao, C.; Gardner, T. A. // Cancer Gene Therapy;Mar2010, Vol. 17 Issue 3, p180 

    In this study, we analyzed the preclinical utility and antitumor efficacy of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) delivered by Ad-IU2, a prostate-specific replication-competent adenovirus (PSRCA), against androgen-independent prostate cancer. Through transcriptional...

  • CD30.  // Encyclopedic Reference of Cancer;2001, p171 

    A definition of the term "CD30" is presented. It refers to a member of the tumor necrosis factor/ nerve growth factor receptor superfamily. CD30 is an activation-associated antigen that is most often expressed on lymphoid cells, but also found on embryonal carcinoma cells.

  • Lymphotoxin and lipopolysaccharide induce NF-?B-p52 generation by a co-translational mechanism. Mordm�ller, Benjamin; Krappmann, Daniel; Esen, Meral; Wegener, Elmar; Scheidereit, Claus // EMBO Reports;Jan2003, Vol. 4 Issue 1, p82 

    The 'classical' NF-?B activation pathway proceeds via I?B kinase (IKK)-�/?-mediated phosphorylation, induced ubiquitination and the degradation of small I?Bs. An alternative, NF-?B-inducing kinase and IKK-a-dependent pathway, which stimulates the processing of NF-?B2/p100, has recently been...

  • The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. Devin, Anne; Yong Lin; zheng-gang Liu // EMBO Reports;Jun2003, Vol. 4 Issue 6, p623 

    The death-domain kinase RIP (receptor-interacting protein) is an important effector of tumour necrosis factor (TNF) signalling and is essential for TNF-induced nuclear factor-?B activation. However, the function of RIP in the TNF-induced activation of mitogen-activated protein kinases (MAPKs)...

  • TACI is mutant in common variable immunodeficiency and IgA deficiency. Castigli, Emanuela; Wilson, Stephen A.; Garibyan, Lilit; Rachid, Rima; Bonilla, Francisco; Schneider, Lynda; Geha, Raif S. // Nature Genetics;Aug2005, Vol. 37 Issue 8, p829 

    The tumor necrosis factor receptor family member TACI (transmembrane activator and calcium-modulator and cyclophilin ligand interactor) mediates isotype switching in B cells. We found that 4 of 19 unrelated individuals with common variable immunodeficiency (CVID) and 1 of 16 individuals with IgA...


Read the Article


Sign out of this library

Other Topics